Nemolizumab is safe and effective for long-term use in patients with moderate-to-severe atopic dermatitis, an extension study shows.

Eli Lilly has signed a licensing deal with Cipla to market its blockbuster weight-loss drug under the brand name Yurpeak in ...

The FSSAI has banned food companies from using "ORS" on labels to prevent the sale of sugary drinks falsely marketed as ...

By Bhanvi Satija and Ludwig Burger FRANKFURT (Reuters) -Shares of Swiss drugmaker Roche fell on Thursday after sales of its ...

Eli Lilly has teamed up with Cipla to market its popular weight-loss drug Mounjaro in India. The medication, which is used ...

Eli Lilly and Company is a Strong Buy due to strong growth in obesity and diabetes drugs and pipeline innovation. Learn more ...